gefitinib has been researched along with cc-292 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (cc-292) | Trials (cc-292) | Recent Studies (post-2010) (cc-292) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 33 | 5 | 32 |
| Protein | Taxonomy | gefitinib (IC50) | cc-292 (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | 0.5337 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.442 | |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | 4.4 | |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | 0.0062 | |
| Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | 2.665 | |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 0.4626 | |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | 0.1163 | |
| Early activation antigen CD69 | Homo sapiens (human) | 3.1 | |
| Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | 0.5337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Li, Y; Liu, K; Ma, T; Ma, X; Sun, H; Sun, X; Wang, C; Zheng, X; Zhu, Y | 1 |
1 other study(ies) available for gefitinib and cc-292
| Article | Year |
|---|---|
Synthesis and biological activity of thieno[3,2-d]pyrimidines as potent JAK3 inhibitors for the treatment of idiopathic pulmonary fibrosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Female; Humans; Idiopathic Pulmonary Fibrosis; Janus Kinase 3; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship | 2020 |